Don’t Throw The Baby Out With The Bathwater: The Benefits Of PSA Testing

Speaker: Dr. Andrew Loblaw
Original Date: Thursday November 6, 2014

In response to the recommendations against PSA testing by the Canadian Task Force on Preventative Health Care, this Expert Angle webinar highlights the benefits of PSA testing with Dr. Andrew Loblaw.  In particular, Dr. Loblaw discusses:
  • the importance of active surveillance and its adoption in Canada
  • the need to measure baseline PSA to determine prostate cancer risk
  • the use of modeling data to augment cohort data



Dr. Andrew Loblaw

andrew_loblaw.jpgDr. Andrew Loblaw is a Radiation Oncologist, Clinician Scientist and Associate Professor in the Departments of Radiation Oncology and Health Policy Management and Evaluation at the University of Toronto. He has a Masters in Clinical Epidemiology from the University of Toronto and is a graduate of the Royal College’s Clinician Investigator Program. Dr. Loblaw’s clinical practice focuses on prostate cancer. He has a research interest in improving outcomes for men with prostate cancer, particularly determining the optimal timing of salvage androgen deprivation therapy, and the outcomes of active surveillance and image-guided radiotherapy. Dr. Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Scientist at the Sunnybrook Research Institute. He is the North American Editor for Clinical Oncology and the Co-Chair of the American Society of Clinical Oncology’s Genitourinary Advisory Group and Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 150 peer-reviewed papers and has been awarded grant funding of over $12 million dollars.

About Canadian Cancer Survivor Network (CCSN)

Prostate Cancer Canada is co-hosting this Expert Angle with CCSN.

CCSN is an organization committed to developing public policy on cancer issues and increasing advocacy for optimal cancer care and follow-up. CCSN works to connect patients, survivors and other stakeholder groups with decision makers and the wider community to engage in discussion and to act on evidence-based best practices to alleviate the medical, emotional, financial and social costs of cancer and encourage research on ways to overcome barriers to optimal cancer care and follow-up for survivors in Canada.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

 

Help us take the first steps toward prevention. Donate Now




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Do men’s toenails contain clues about prostate cancer prevention?

Toronto, January 29, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More


Click here for news archive